Quarterly report pursuant to Section 13 or 15(d)

Condensed Balance Sheets

v3.7.0.1
Condensed Balance Sheets - USD ($)
Jun. 30, 2017
Dec. 31, 2016
Current asset:    
Cash and cash equivalents $ 577,611 $ 67,250
Prepaid expenses 29,908
Total current assets 607,519 67,250
Deferred offering costs 172,750
Cash and marketable securities held in Trust Account 116,205,729
Total Assets 116,813,248 240,000
Current liabilities:    
Accounts payable and accrued expenses 105,756 78,105
Due to related party 7,000
Note payable - related party 140,000
Total current liabilities 112,756 218,105
Deferred underwriting fees 4,025,000
Total Liabilities 4,137,756 218,105
Commitments
Common stock subject to possible redemption, $0.0001 par value; 10,660,939 and -0- shares as of June 30, 2017 and December 31, 2016, respectively (at redemption value of $10.10 per share) 107,675,484
Stockholders' Equity:    
Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding as of June 30, 2017 and December 31, 2016
Common stock, $0.0001 par value; 35,000,000 shares authorized; 4,216,561 and 2,875,000 shares issued and outstanding (excluding 10,660,939 and -0- shares subject to possible redemption) as of June 30, 2017 and December 31, 2016, respectively 422 287
Additional paid-in capital 5,028,658 24,713
Accumulated deficit (29,072) (3,105)
Total Stockholders' Equity 5,000,008 21,895
Total Liabilities and Stockholders' Equity $ 116,813,248 $ 240,000